Core Points - SenesTech, Inc. will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025, with a webcast presentation and one-on-one meetings with investors [1][3] - The webcast presentation is scheduled for 2:45 p.m. ET and will be accessible online, with a replay available after the event [2] - SenesTech focuses on humane management of animal pest populations through fertility control, with products like Evolve rodent birth control enhancing pest management effectiveness [3] Company Overview - SenesTech is dedicated to creating healthier environments by managing animal pest populations humanely through fertility control [3] - The company's mission includes creating cleaner cities, more efficient businesses, and healthier communities with humane, effective, and sustainable products [3] Contact Information - For investor inquiries, Robert Blum from Lytham Partners can be contacted at 602-889-9700 [6] - Tom Chesterman, Chief Financial Officer of SenesTech, can be reached at 928-779-4143 for company-related inquiries [6]

Core Viewpoint - SenesTech, Inc. has successfully closed the exercise of outstanding warrants, raising approximately $6.3 million, and issued new short-term warrants for additional capital [1][4]. Group 1: Financial Details - The company exercised warrants to purchase 1,458,872 shares at an exercise price of $4.15 per share [1]. - New unregistered short-term warrants were issued to purchase up to 2,188,308 shares at an exercise price of $5.25 per share, with a purchase price of $0.125 per warrant [3]. - The potential gross proceeds from the new short-term warrants, if fully exercised, could amount to approximately $11.5 million [4]. Group 2: Use of Proceeds - The net proceeds from the transaction are expected to be used for working capital and general corporate purposes [4]. Group 3: Company Overview - SenesTech is focused on humane management of animal pest populations through fertility control, with products like ContraPest® and Evolve™ [8]. - ContraPest® is the only U.S. EPA-registered contraceptive for male and female rats, while Evolve™ products are designated as minimum risk contraceptives for rodents [8].